In an in vivo vaccination protocol, an IL-15 encoding plasmid linked to TAT CPP and survivin epitope increased the percentage of survivin-specific CD8 T cells with lytic function towards CT26 tumor cells. This evidence concerns the gene BIRC5 and neoplasm.